Study of XVIE injection for male and female pattern hair loss
Part of Skin clinical trials.
This trial tests an investigational treatment called XVIE, given as an injection into the scalp, to see if it can help people with male or female pattern hair loss. It may be an option for those who have had stable hair loss for at least six months and are not currently using other hair loss treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have had hair loss for at least 6 months, with no sudden worsening in that time.
- For men: your hair loss matches certain patterns (like a receding hairline or thinning on top). For women: your hair thinning is mild to moderate.
- You have not used certain hair loss treatments recently, such as minoxidil (like Rogaine) in the last 3 months, finasteride (like Propecia) in the last 6 months, or hair transplant surgery in the past year.
- You are generally in good health and do not have other scalp conditions or autoimmune diseases.
- If you are a woman who could become pregnant, you must use contraception and have a negative pregnancy test.
- You have not had platelet-rich plasma (PRP) or similar scalp injections in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.
This trial tests whether injecting exosomes, tiny particles from cells, into the scalp can help regrow hair in men with common male pattern baldness. It's an early-stage study that also looks at how the treatment affects hair follicles.
This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.
This study tests an experimental medication (CKD-843) for men with male pattern baldness. It aims to see if the treatment is safe and effective for regrowing hair.
This trial compares different in-office procedures (like injections, lasers, or platelet-rich plasma) to treat male pattern hair loss. It aims to find which method works best to help hair grow back or stop thinning. Participation could provide access to new treatments that target the root cause of hair loss.
This trial tests whether a new gel called Xvie, delivered into the scalp with tiny needles (microneedling), can help women who feel their hair is thinning. You will get the treatment in a clinic, and the study will see if it makes your hair look fuller.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.